Formative research tells us that many people living with eczema are facing significant challenges in understanding how to best manage their condition and in navigating the treatment maze. Inconsistencies in educational materials and guidance at crucial stages can leave individuals and parents of children with eczema feeling challenged and overwhelmed from the start.
This is compounded by the vast range and volume of treatment options available., The choices can be overwhelming and made even more daunting by the often-vague accompanying instructions such as “use twice a day”, “use after showering”, “use for this part of the body” or “use for sensitive parts of the body”. Even health professionals can find these instructions a challenge to interpret.
And if this wasn’t already confusing enough, patients are also left to navigate instructions from multiple care providers who often provide contradicting information. The use of topical corticosteroids is a good example of this. Consumers could be told to apply liberally, sparingly, or judiciously, to use a fingertip or to think in terms of number of tubes, to use for one week, or two weeks or until the eczema goes away.
Compounding all of this is the limited time available for patients to work out day-to-day practicalities of treatment and management with their health professionals. Time is a premium for all, but sadly when it comes to eczema management it’s the patient who pays the price.
In desperation, many patients turn to the internet where they encounter a unique range of “specialists”, often through social media, and a minefield of misinformation and disinformation, particularly regarding the use of topical corticosteroids. Desperation can also lead to demand for alternative and questionable remedies that invariably disappoint and often contribute to the financial burden of the condition. And for patients who hear about new treatments but are not eligible to access them, the system may seem to be unfair, leading to distrust of health professionals and the health system which seemingly fails to provide the help they need.
The Quality Use of Medicines Alliance aims to address these challenges through a multifaceted program of activities that will improve management and quality of life for patients living with eczema.
For health professionals, a variety of opportunities will be made available including face-to-face education, peer group learning, webinars, podcasts, decision algorithms, communication videos and an action plan for use in patient consultations. For consumers there will be bespoke resources such as videos, digital content and a dedicated information hub comprising trusted sources of information. Together, these opportunities are set to make life better for the 3 million Australians living with eczema.
It's time to end the struggle for eczema sufferers.
The Eczema Equation: Burden of disease and challenges in management is a free webinar providing an up-to-date overview of eczema and its challenges.
Further opportunities to improve eczema management will be available for health professionals on the Medcast QHUB.
Explore patient-centred strategies for managing antidepressant use in older adults using the mnemonic CARE as a framework for effective decision-making, monitoring, and deprescribing. Learn how the Quality Use of Medicines Alliance promotes safer, tailored approaches to mental health management in older populations.
Diet and alcohol intake are no longer thought to play as big a role in gout as previously thought, yet patients with gout often show great interest in how they can improve their diet. Below are answers to common myths.
Gout, a common yet preventable condition, is not as benign as once thought. While it has long been suggested that people with gout are at increased risk of cardiovascular disease and mortality, the association has been complex and unclear. Recent evidence has improved our understanding of this link.